13 November 2023
13 November 2023
The year-long study tested Medtronic’s spinal cord stimulation device against conventional therapy.
The assay's capability to identify colorectal cancer in average-risk individuals was validated in the ECLIPSE study.
Telix will acquire 19.33% of Mauna Kea’s ordinary shares in a reserved private placement, with the deal closing on 17 November 2023.
Genome Health leverages NGS technology for identifying risk alleles linked to major cancer types.
The approval enables individuals to test their samples at ARUP's central laboratory located in Salt Lake City.
The Paradise uRDN system was assessed through the company’s RADIANCE Global Programme.
At the FT Global Pharma and Biotech Summit in London, various industry players shared their thoughts on technological and regulatory advancements.
Marking a massive step in the facial reconstruction field NYU Langone Health has made the first whole eye and partial face transplant from a single donor.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
With rising pressure on governments, payers, and manufacturers to reduce healthcare costs, innovative medical technologies have tremendous potential to improve elder care. Advancements in medical device technology have resulted in a significant increase in the number of conditions that can be managed in a home care setting. To capitalize on this strong demand and growth, manufacturers are increasingly producing consumer-targeted equipment.
Give your business an edge with our leading industry insights.
